echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Cell: Mechanism of action of GPCRs

    Cell: Mechanism of action of GPCRs

    • Last Update: 2022-05-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    About a third of all drugs approved by the U.


    Now, an interdisciplinary research team has gained a new understanding of how GPCRs work, taking a step toward developing improved drugs with fewer side effects


    "Drugs targeting GPCRs are used to treat a wide variety of medical conditions -- heart disease, lung disease, sleep and neuropsychiatric disorders -- and GPCRs are also responsible for smell, taste, and vision," said Columbia University Vagelos College of Surgeons said Jonathan A.


    But like many therapies, drugs that target GPCRs often have side effects, some of which can be serious


    "In our study, we used an approach that allowed us to explore, in unprecedented detail, how drug-stimulated GPCRs activate β-arrestin, a protein that both terminates some signals and mediates others


    The study, published April 27 in the journal Cell, used a cutting-edge technique called single-molecule fluorescence resonance energy transfer (smFRET) imaging


    Armed with smFRET, the team decided to probe - adrenergic receptors - a prototype GPCR that is broadly relevant to many different areas of biology


    By looking at the activation of β-arrestin by β-arrestin adrenergic receptors, the researchers revealed new details of how β-arrestin interacts with, and is activated by, GPCRs, both of which are required to release autoinhibition


    This finding may ultimately help identify improved drugs that affect specific pathways, but not others, by modulating the binding and/or activation of β-arrestin to GPCRs


    The results of this study also support the "barcode hypothesis" that different phosphorylation patterns or "barcodes" within receptors can lead to different β-arrestin activation patterns, which in turn determine downstream signaling outcomes


    The scientists hope that a better understanding of the relationship between receptor "barcoding" and beta-arrestin activation can provide important insights into how specific pathways downstream, but not others, are targeted


    GPCR-mediated beta-arrestin activation deconvoluted with single-molecule precision



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.